Standard

Molecular biological problems of drug design and mechanism of drug action : Organic hydrogen sulfide donor compounds with cardioprotective properties (review). / Tkacheva, N. I.; Morozov, S. V.; Lomivorotov, B. B. et al.

In: Pharmaceutical Chemistry Journal, Vol. 51, No. 3, 06.2017, p. 165-174.

Research output: Contribution to journal › Review article › peer-review

Harvard

Tkacheva, NI, Morozov, SV, Lomivorotov, BB & Grigor’ev, IA 2017, 'Molecular biological problems of drug design and mechanism of drug action: Organic hydrogen sulfide donor compounds with cardioprotective properties (review)', Pharmaceutical Chemistry Journal, vol. 51, no. 3, pp. 165-174. https://doi.org/10.1007/s11094-017-1576-5

APA

Tkacheva, N. I., Morozov, S. V., Lomivorotov, B. B., & Grigor’ev, I. A. (2017). Molecular biological problems of drug design and mechanism of drug action: Organic hydrogen sulfide donor compounds with cardioprotective properties (review). Pharmaceutical Chemistry Journal, 51(3), 165-174. https://doi.org/10.1007/s11094-017-1576-5

Vancouver

Tkacheva NI, Morozov SV, Lomivorotov BB, Grigor’ev IA. Molecular biological problems of drug design and mechanism of drug action: Organic hydrogen sulfide donor compounds with cardioprotective properties (review). Pharmaceutical Chemistry Journal. 2017 Jun;51(3):165-174. doi: 10.1007/s11094-017-1576-5

Author

Tkacheva, N. I. ; Morozov, S. V. ; Lomivorotov, B. B. et al. / Molecular biological problems of drug design and mechanism of drug action : Organic hydrogen sulfide donor compounds with cardioprotective properties (review). In: Pharmaceutical Chemistry Journal. 2017 ; Vol. 51, No. 3. pp. 165-174.

BibTeX

@article{089d1e631cbe49e3b30f5962584bbd98,
title = "Molecular biological problems of drug design and mechanism of drug action: Organic hydrogen sulfide donor compounds with cardioprotective properties (review)",
abstract = "This review summarizes published data on organic hydrogen sulfide donor compounds, including hybrid compounds, and their roles in cardioprotection.",
keywords = "Cardioprotection, Cardiovascular system, Hybrid compounds, Hydrogen sulfide, Organic HS donors, cardiovascular system, EFFECTS IN-VITRO, PLATELET-AGGREGATION, MUSCLE-CELL PROLIFERATION, MYOCARDIAL-ISCHEMIA, MEDIATES CARDIOPROTECTION, hybrid compounds, ISCHEMIA-REPERFUSION INJURY, H2S DONORS, S-PROPARGYL-CYSTEINE, hydrogen sulfide, organic H2S donors, cardioprotection, NITRIC-OXIDE, PHARMACOLOGICAL EVALUATION",
author = "Tkacheva, {N. I.} and Morozov, {S. V.} and Lomivorotov, {B. B.} and Grigor{\textquoteright}ev, {I. A.}",
year = "2017",
month = jun,
doi = "10.1007/s11094-017-1576-5",
language = "English",
volume = "51",
pages = "165--174",
journal = "Pharmaceutical Chemistry Journal",
issn = "0091-150X",
publisher = "Springer New York",
number = "3",

}

RIS

TY - JOUR

T1 - Molecular biological problems of drug design and mechanism of drug action

T2 - Organic hydrogen sulfide donor compounds with cardioprotective properties (review)

AU - Tkacheva, N. I.

AU - Morozov, S. V.

AU - Lomivorotov, B. B.

AU - Grigor’ev, I. A.

PY - 2017/6

Y1 - 2017/6

N2 - This review summarizes published data on organic hydrogen sulfide donor compounds, including hybrid compounds, and their roles in cardioprotection.

AB - This review summarizes published data on organic hydrogen sulfide donor compounds, including hybrid compounds, and their roles in cardioprotection.

KW - Cardioprotection

KW - Cardiovascular system

KW - Hybrid compounds

KW - Hydrogen sulfide

KW - Organic HS donors

KW - cardiovascular system

KW - EFFECTS IN-VITRO

KW - PLATELET-AGGREGATION

KW - MUSCLE-CELL PROLIFERATION

KW - MYOCARDIAL-ISCHEMIA

KW - MEDIATES CARDIOPROTECTION

KW - hybrid compounds

KW - ISCHEMIA-REPERFUSION INJURY

KW - H2S DONORS

KW - S-PROPARGYL-CYSTEINE

KW - hydrogen sulfide

KW - organic H2S donors

KW - cardioprotection

KW - NITRIC-OXIDE

KW - PHARMACOLOGICAL EVALUATION

UR - http://www.scopus.com/inward/record.url?scp=85054532039&partnerID=8YFLogxK

U2 - 10.1007/s11094-017-1576-5

DO - 10.1007/s11094-017-1576-5

M3 - Review article

VL - 51

SP - 165

EP - 174

JO - Pharmaceutical Chemistry Journal

JF - Pharmaceutical Chemistry Journal

SN - 0091-150X

IS - 3

ER -

ID: 10183903